Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Green Cross Wins Bid To Supply Chicken Pox Vaccine to WHO

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's leading vaccine maker Green Cross has won another round of international bidding to supply the World Health Organization's Pan American Health Organization with its chicken pox vaccine Suduvax worth $10.4 million
Advertisement

Related Content

Green Cross Becomes First Korean Pharma To Export Flu Vaccine
Green Cross Becomes First Korean Pharma To Export Flu Vaccine
Demand For A/H1N1 Vaccine Catapults Green Cross Into No. 2 Spot In Korea; Company Ramps Up Biosimilar Pipeline
Demand For A/H1N1 Vaccine Catapults Green Cross Into No. 2 Spot In Korea; Company Ramps Up Biosimilar Pipeline
Korea's Green Cross Gets Green Light From KFDA To Produce Novartis Adjuvanted A/H1N1 Vaccine
Korea FDA Allows Emergency Use Of Intravenous Peramivir for Seriously Ill A/H1N1 Patients
Korea FDA Allows Emergency Use Of Intravenous Peramivir for Seriously Ill A/H1N1 Patients
Advertisement
UsernamePublicRestriction

Register

SC073010

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel